Prevention of vector-borne diseases and military medical support

Wenyue XU; Xiaofeng XU

doi:10.16016/j.10005404.202112035

您当前的位置：

首页 >

文章列表页 >

Prevention of vector-borne diseases and military medical support

Military Medicine | 更新时间：2026-01-09

- Prevention of vector-borne diseases and military medical support
- Journal of Army Medical University Vol. 44, Issue 1, Pages: 9-15(2022)
- 作者机构：
  
  1.400038 重庆，陆军军医大学（第三军医大学）基础医学院：病原生物学教研室
  2.400038 重庆，陆军军医大学（第三军医大学）基础医学院：医学遗传学教研室
- 作者简介：
- 基金信息：
  
  the Key Program of National Natural Science Foundation of China(81830067);the General Program of National Natural Science Foundation of China(82172296)
- DOI：10.16016/j.10005404.202112035
  CLC： R183.5;R824.2
- Received：05 December 2021，
  
  Revised：2021-12-13，
  
  Published：15 January 2022
- 稿件说明：
移动端阅览
Wenyue XU, Xiaofeng XU. Prevention of vector-borne diseases and military medical support[J]. Journal of Army Medical University, 2022, 44(1): 9-15.
DOI：

Wenyue XU, Xiaofeng XU. Prevention of vector-borne diseases and military medical support[J]. Journal of Army Medical University, 2022, 44(1): 9-15. DOI： 10.16016/j.10005404.202112035.

摘要

虫媒病不但是全球公共卫生问题，而且也是影响世界各国军队卫勤保障的重要问题。媒介生物的有效控制和叮咬防护手段的研制能从群体水平上控制和预防各种虫媒病的流行和传播，而针对具体虫媒病的特异性疫苗和药物的研制则能有效预防特定虫媒病的感染。虽然目前在媒介生物控制、驱避剂和疟疾疫苗研制等方面取得了显著的进展，但仍然缺乏安全、高效的虫媒病防控手段，有待于在基因驱动改造媒介生物种群、昆虫寻找宿主和机体抗虫媒病原体保护性免疫机制等方面展开深入研究。

Abstract

Vector-borne diseases are not only global public health issues

but also a great concern to military medical support. Strategies to biologically control vector and prevent vector bites can protect population from infection with vector-borne diseases at community levels

and the development of effective vaccines and drugs could prevent the infection of a given important vector-borne disease. Although great progress has been achieved in the researches on vector control and repellents and malaria vaccine

highly effective measures to prevent vector-borne diseases are still lack. Therefore

it is still urgent to explore the underlying mechanism of genetic manipulation of vector populations by gene drive system

and host seeking by vectors

as well as host protective immune responses against major vector-borne diseases in the future.

关键词

Keywords

references

PAGES F, FAULDE M, ORLANDI-PRADINES E, et al . The past and present threat of vector-borne diseases in deployed troops[J ] . Clin Microbiol Infect, 2010, 16(3): 209-224.

DAME D A, CURTIS C F, BENEDICT M Q, et al . Historical applications of induced sterilisation in field populations of mosquitoes[J ] . Malar J, 2009, 8(Suppl 2): S2. DOI: 10.1186/1475-2875-8-s2-s2.

HELINSKI M E, PARKER A G, KNOLS B G. Radiation biology of mosquitoes[J]. Malar J, 2009, 8(Suppl 2): S6. DOI: 10.1186/1475-2875-8-S2-S6.

LEES R S, GILLES J R, HENDRICHS J, et al . Back to the future: the sterile insect technique against mosquito disease vectors[J ] . Curr Opin Insect Sci, 2015, 10: 156-162. DOI: 10.1016/j.cois.2015.05.011.

LAVEN H. Eradication of Culex pipiens fatigans through cytoplasmic incompatibility[J]. Nature, 1967, 216(5113): 383-384. DOI: 10.1038/216383a0.

ZHENG X Y, ZHANG D J, LI Y J, et al . Incompatible and sterile insect techniques combined eliminate mosquitoes[J ] . Nature, 2019, 572(7767): 56-61. DOI: 10.1038/s41586-019-1407-9.

BURT A. Site-specific selfish genes as tools for the control and genetic engineering of natural populations[J]. Proc Biol Sci, 2003, 270(1518): 921-928. DOI: 10.1098/rspb.2002.2319.

HAMMOND A, GALIZI R, KYROU K, et al . A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae[J ] . Nat Biotechnol, 2016, 34(1): 78-83. DOI: 10.1038/nbt.3439.

KYROU K, HAMMOND A M, GALIZI R, et al . A CRISPR-Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes[J ] . Nat Biotechnol, 2018, 36(11): 1062-1066. DOI: 10.1038/nbt.4245.

NIGHORN A, HILDEBRAND J G. Dissecting the molecular mechanisms of olfaction in a malaria-vector mosquito[J]. Proc Natl Acad Sci USA, 2002, 99(3): 1113-1114. DOI: 10.1073/pnas.042708099.

HALLEM E A, NICOLE FOX A, ZWIEBEL L J, et al . Olfaction: mosquito receptor for human-sweat odorant[J ] . Nature, 2004, 427(6971): 212-213. DOI: 10.1038/427212a.

JONES W D, CAYIRLIOGLU P, GRUNWALD KADOW I, et al . Two chemosensory receptors together mediate carbon dioxide detection in drosophila[J ] . Nature, 2007, 445(7123): 86-90. DOI: 10.1038/nature05466.

SCHOENIG G P, OSIMITZ T G, GABRIEL K L, et al . Evaluation of the chronic toxicity and oncogenicity of N, N-diethyl-m-toluamide (DEET)[J ] . Toxicol Sci, 1999, 47(1): 99-109. DOI: 10.1093/toxsci/47.1.99.

FREEMAN E G, WISOTSKY Z, DAHANUKAR A. Detection of sweet tastants by a conserved group of insect gustatory receptors[J]. Proc Natl Acad Sci USA, 2014, 111(4): 1598-1603. DOI: 10.1073/pnas.1311724111.

GREPPI C, LAURSEN W J, BUDELLI G, et al . Mosquito heat seeking is driven by an ancestral cooling receptor[J ] . Science, 2020, 367(6478): 681-684. DOI: 10.1126/science.aay9847.

MOLINA-CRUZ A, GARVER L S, ALABASTER A, et al . The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system[J ] . Science, 2013, 340(6135): 984-987. DOI: 10.1126/science.1235264.

MOLINA-CRUZ A, DEJONG R J, ORTEGA C, et al . Some strains of Plasmodium falciparum, a human malaria parasite, evade the complement-like system of Anopheles gambiae mosquitoes[J ] . Proc Natl Acad Sci USA, 2012, 109(28): E1957-E1962. DOI: 10.1073/pnas.1121183109.

CIRIMOTICH C M, DONG Y M, CLAYTON A M, et al . Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae[J ] . Science, 2011, 332(6031): 855-858. DOI: 10.1126/science.1201618.

PAN X, ZHOU G, WU J, et al . Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti[J ] . Proc Natl Acad Sci USA, 2012, 109(1): E23-E31. DOI: 10.1073/pnas.1116932108.

ZHU Y B, TONG L Q, NIE K X, et al . Host serum iron modulates dengue virus acquisition by mosquitoes[J ] . Nat Microbiol, 2019, 4(12): 2405-2415. DOI: 10.1038/s41564-019-0555-x.

ZHU Y, ZHANG R, ZHANG B, et al . Blood meal acquisition enhances arbovirus replication in mosquitoes through activation of the GABAergic system[J ] . Nat Commun, 2017, 8(1): 1262. DOI: 10.1038/s41467-017-01244-6.

DREXLER A L, PIETRI J E, PAKPOUR N, et al . Human IGF1 regulates midgut oxidative stress and epithelial homeostasis to balance lifespan and Plasmodium falciparum resistance in Anopheles stephensi[J ] . PLoS Pathog, 2014, 10(6): e1004231. DOI: 10.1371/journal.ppat.1004231.

SMITH A A, NAVASA N, YANG X L, et al . Cross-species interferon signaling boosts microbicidal activity within the tick vector[J ] . Cell Host Microbe, 2016, 20(1): 91-98. DOI: 10.1016/j.chom.2016.06.001.

WANG S B, DOS-SANTOS A L A, HUANG W, et al . Driving mosquito refractoriness to Plasmodium falciparum with engineered symbiotic bacteria[J ] . Science, 2017, 357(6358): 1399-1402. DOI: 10.1126/science.aan5478.

HAMMOND A M, KYROU K, BRUTTINI M, et al . The creation and selection of mutations resistant to a gene drive over multiple generations in the malaria mosquito[J ] . PLoS Genet, 2017, 13(10): e1007039. DOI: 10.1371/journal.pgen.1007039.

PHYO A P, NKHOMA S, STEPNIEWSKA K, et al . Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study[J ] . Lancet, 2012, 379(9830): 1960-1966. DOI: 10.1016/S0140-6736(12)60484-X.

UWIMANA A, LEGRAND E, STOKES B H, et al . Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda[J ] . Nat Med, 2021, 27(6): 1113-1115. DOI: 10.1038/s41591-021-01365-y.

AGNANDJI S T, LELL B, Soulanoudjingar S S, et al . First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children[J ] . N Engl J Med, 2011, 365(20): 1863-1875. DOI: 10.1056/NEJMoa1102287.

The RTS, S Clinical Trials Partnership. A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants[J]. N Engl J Med, 2012, 367(24): 2284-2295. DOI: 10.1056/nejmoa1208394.

WHO. Approves historic RTS, S malaria vaccine. [2021-10-07]. https://lenstapesmedcom/who-approves-historic-rtss-malaria-vaccine/2021.

MUELLER A K, LABAIED M, KAPPE S H, et al . Genetically modified Plasmodium parasites as a protective experimental malaria vaccine[J ] . Nature, 2005, 433(7022): 164-167. DOI: 10.1038/nature03188.

ROESTENBERG M, MCCALL M, HOPMAN J, et al . Protection against a malaria challenge by sporozoite inoculation[J ] . N Engl J Med, 2009, 361(5): 468-477. DOI: 10.1056/NEJMoa0805832.

EPSTEIN J E, TEWARI K, LYKE K E, et al . Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity[J ] . Science, 2011, 334(6055): 475-480. DOI: 10.1126/science.1211548.

SEDER R A, CHANG L J, ENAMA M E, et al . Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine[J ] . Science, 2013, 341(6152): 1359-1365. DOI: 10.1126/science.1241800.

GARDNER M J, HALL N, FUNG E, et al . Genome sequence of the human malaria parasite Plasmodium falciparum[J ] . Nature, 2002, 419(6906): 498-511. DOI: 10.1038/nature01097.

KAPTEIN S J F, GOETHALS O, KIEMEL D, et al . Publisher Correction: a Pan-serotype dengue virus inhibitor targeting the NS3-NS4B interaction[J ] . Nature, 2021, 599(7883): E2. DOI: 10.1038/s41586-021-04123-9.

MOQUIN S A, SIMON O, KARUNA R, et al . NITD-688, a Pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models[J ] . Sci Transl Med, 2021, 13(579): eabb2181. DOI: 10.1126/scitranslmed.abb2181.

CAPEDING M R, TRAN N H, HADINEGORO S R, et al . Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial[J ] . Lancet, 2014, 384(9951): 1358-1365. DOI: 10.1016/S0140-6736(14)61060-6.

VILLAR L, DAYAN G H, ARREDONDO-GARCÍA J L, et al . Efficacy of a tetravalent dengue vaccine in children in Latin America[J ] . N Engl J Med, 2015, 372(2): 113-123. DOI: 10.1056/nejmoa1411037.

Dengue vaccine: WHO position paper, September 2018-recommendations[J]. Vaccine, 2019, 37(35): 4848-4849. DOI: 10.1016/j.vaccine.2018.09.063.

SIRIVICHAYAKUL C, BARRANCO-SANTANA E A, RIVERA I E, et al . Long-term safety and immunogenicity of a tetravalent dengue vaccine candidate in children and adults: a randomized, placebo-controlled, phase 2 study[J ] . J Infect Dis, 2020. DOI: 10.1093/infdis/jiaa406.

BISWAL S, BORJA-TABORA C, MARTINEZ VARGAS L, et al . Efficacyof a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial[J ] . Lancet, 2020, 395(10234): 1423-1433. DOI: 10.1016/S0140-6736(20)30414-1.

WEISKOPF D, AN GELO M A, BANGS D J, et al . The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes[J ] . J Virol, 2015, 89(1): 120-128. DOI: 10.1128/jvi.02129-14.

ANGELO M A, GRIFONI A, O'ROURKE P H, et al . Human CD4 + T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity[J ] . J Virol, 2017, 91(5): e02147-16. DOI: 10.1128/jvi.02147-16.

KATZELNICK L C, ZAMBRANA J V, ELIZONDO D, et al . Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term[J ] . Sci Transl Med, 2021, 13(614): eabg9478. DOI: 10.1126/scitranslmed.abg9478.

SMITH G J, VIJAYKRISHNA D, BAHL J, et al . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic[J ] . Nature, 2009, 459(7250): 1122-1125.

WANG Z D, WANG B, WEI F, et al . A new segmented virus associated with human febrile illness in China[J ] . N Engl J Med, 2019, 380(22): 2116-2125. DOI: 10.1056/NEJMoa1805068.

ZHOU P, YANG X L, WANG X G, et al . Addendum: a pneumonia outbreak associated with a new coronavirus of probable bat origin[J ] . Nature, 2020, 588(7836): E6. DOI: 10.1038/s41586-020-2951-z.

PARRISH C R, HOLMES E C, MORENS D M, et al . Cross-species virus transmission and the emergence of new epidemic diseases[J ] . Microbiol Mol Biol Rev, 2008, 72(3): 457-470. DOI:10.1128/MMBR.00004-08.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Current status and prospect for development of COVID-19 vaccine adjuvants

Advances in prevention and control for dengue fever

Development and evaluation of a differential diagnostic test strip for antibodies induced by HIV-1 vaccine and natural infections

Epithelial membrane protein 2 peptide vaccine in immunological control of breast carcinoma in mice

Prospect for vaccines to prevent superbug infection

Related Author

Hao CHENG

Haibo LI

Jintao LI

Yangmin YE

Jun HUANG

Yonghong WANG

Zuowei YUAN

许颖

Related Institution

Department of Microbiology and Biochemical Pharmacy, National Engineering Research Center of Immunological Products, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)

Department of Military Biosafety, College of Basic Medical Sciences, Army Medical University (Third Military Medical University)

Department of Laboratory Medicine, Qianjiang Central Hospital

Department of Blood Transfusion, Qianjiang Central Hospital

⁰